England’s National Health Service (NHS) is set to expand its treatment options for chronic heart failure (CHF) with the National…
Read More
GLP-1 Blockbusters Propel Pharma R&D Returns to 7%, Masking Broader Productivity Challenges, Deloitte Report Reveals
After a prolonged period where growth remained uneven in the wake of global disruptions, a pivotal metric for biopharma research…
Read More
Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…
Read More
FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts
Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…
Read MoreYOU MAY HAVE MISSED
